|
|
 |
|
Viewing report
|
|
|
|
Chugai Pharmaceutical Co., Ltd. - SWOT Analysis
Datamonitor, Sep 2011, Pages: 22
Chugai Pharmaceutical Co., Ltd. - SWOT Analysis company profile is the essential source for top-level company data and information. Chugai Pharmaceutical Co., Ltd. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Chugai Pharmaceutical (Chugai), the Japanese subsidiary of the Roche Group, is engaged in biopharmaceutical research and development. It produces antibody drugs, focused in the three areas, oncology, renal diseases and bone and joint diseases. The company operates in Europe, Americas and Asia Pacific. It is headquartered in Tokyo, Japan and employed 6,709 people as of December 31, 2010. The company recorded revenues of JPY379,510 million (approximately $4,326.4 million) during the financial year ended December 2010 (FY2010), a decrease of 11.5% compared with FY2009. The operating profit of the company was JPY66,238 million (approximately $755.1 million) during FY2010, a decrease of 19.8% compared with FY2009. The net profit was JPY41,433 million (approximately $472.3 million) in FY2010, a decrease of 26.8% compared with FY2009.
Scope of the Report
- Provides all the crucial information on Chugai Pharmaceutical Co., Ltd. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Chugai Pharmaceutical Co., Ltd. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Chugai Pharmaceutical Co., Ltd.
-Data is supplemented with details on Chugai Pharmaceutical Co., Ltd. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Chugai Pharmaceutical Co., Ltd.
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Customers who bought this item also bought
Chugai Pharmaceutical Co., Ltd. - Strategy and SWOT Report
Kuraray Co., Ltd. - SWOT Analysis
Chugai Pharmaceutical Co., Ltd. (4519) - Financial and Strategic SWOT Analysis Review
Furukawa Co., Ltd. - SWOT Analysis
Yamada Denki Co., Ltd. - SWOT Analysis
SANYO Electric Co., Ltd. SWOT Analysis
Sony Corporation - SWOT Analysis
Fuji Electric Co., Ltd. - SWOT Analysis
Cosmo Oil Co., Ltd. - SWOT Analysis
Secom Co., Ltd. - SWOT Analysis
|
|
|
|
